Eulexin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Waylis Therapeutics Llc. The primary component is Flutamide.
Product ID | 80725-600_7c581273-b507-4c4b-bcda-fa67a21b1c56 |
NDC | 80725-600 |
Product Type | Human Prescription Drug |
Proprietary Name | Eulexin |
Generic Name | Flutamide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-11-12 |
Marketing Category | ANDA / |
Application Number | ANDA075298 |
Labeler Name | Waylis Therapeutics LLC |
Substance Name | FLUTAMIDE |
Active Ingredient Strength | 125 mg/1 |
Pharm Classes | Androgen Receptor Antagonists [MoA], Androgen Receptor Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-11-12 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
80725-600 | Eulexin | Flutamide |
0591-2466 | Flutamide | Flutamide |
49884-753 | Flutamide | Flutamide |
60429-272 | Flutamide | Flutamide |
69097-915 | FLUTAMIDE | FLUTAMIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EULEXIN 90056265 not registered Live/Pending |
Woodward Pharma Services LLC 2020-07-16 |
EULEXIN 73775571 1556519 Dead/Cancelled |
SCHERING CORPORATION 1989-01-19 |
EULEXIN 73342623 1222342 Dead/Cancelled |
Schering Corporation 1981-12-21 |